Unknown

Dataset Information

0

Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R- Transcriptional Signature Express Fc?RIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity.


ABSTRACT: HIV-1 infection expands large populations of late-stage differentiated CD8 T cells that may persist long after viral escape from TCR recognition. In this study, we investigated whether such CD8 T cell populations can perform unconventional innate-like antiviral effector functions. Chronic untreated HIV-1 infection was associated with elevated numbers of CD45RA+CD57+ terminal effector CD8 T cells expressing Fc?RIIIA (CD16). The Fc?RIIIA+ CD8 T cells displayed a distinctive transcriptional profile between conventional CD8 T cells and NK cells, characterized by high levels of IKZF2 and low expression of IL7R This transcriptional profile translated into a distinct NKp80+ IL-7R?- surface phenotype with high expression of the Helios transcription factor. Interestingly, the Fc?RIIIA+ CD8 T cells mediated HIV-specific Ab-dependent cellular cytotoxicity (ADCC) activity at levels comparable with NK cells on a per cell basis. The Fc?RIIIA+ CD8 T cells were highly activated in a manner that correlated positively with expansion of the CD8 T cell compartment and with plasma levels of soluble mediators of antiviral immunity and inflammation such as IP-10, TNF, IL-6, and TNFRII. The frequency of Fc?RIIIA+ CD8 T cells persisted as patients initiated suppressive antiretroviral therapy, although their activation levels declined. These data indicate that terminally differentiated effector CD8 T cells acquire enhanced innate cell-like characteristics during chronic viral infection and suggest that HIV-specific ADCC is a function CD8 T cells use to target HIV-infected cells. Furthermore, as the Fc?RIIIA+ CD8 T cells persist in treatment, they contribute significantly to the ADCC-capable effector cell pool in patients on antiretroviral therapy.

SUBMITTER: Naluyima P 

PROVIDER: S-EPMC6778306 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity.

Naluyima Prossy P   Lal Kerri G KG   Costanzo Margaret C MC   Kijak Gustavo H GH   Gonzalez Veronica D VD   Blom Kim K   Eller Leigh Anne LA   Creegan Matthew M   Hong Ting T   Kim Dohoon D   Quinn Thomas C TC   Björkström Niklas K NK   Ljunggren Hans-Gustaf HG   Serwadda David D   Katabira Elly T ET   Sewankambo Nelson K NK   Gray Ronald H RH   Baeten Jared M JM   Michael Nelson L NL   Wabwire-Mangen Fred F   Robb Merlin L ML   Bolton Diane L DL   Sandberg Johan K JK   Eller Michael A MA  

Journal of immunology (Baltimore, Md. : 1950) 20190913 8


HIV-1 infection expands large populations of late-stage differentiated CD8 T cells that may persist long after viral escape from TCR recognition. In this study, we investigated whether such CD8 T cell populations can perform unconventional innate-like antiviral effector functions. Chronic untreated HIV-1 infection was associated with elevated numbers of CD45RA<sup>+</sup>CD57<sup>+</sup> terminal effector CD8 T cells expressing FcγRIIIA (CD16). The FcγRIIIA<sup>+</sup> CD8 T cells displayed a di  ...[more]

Similar Datasets

| S-EPMC8406689 | biostudies-literature
| S-EPMC7321885 | biostudies-literature
| S-EPMC6484458 | biostudies-literature
| S-EPMC5505339 | biostudies-literature
| S-EPMC9888687 | biostudies-literature
| S-EPMC6050516 | biostudies-literature
| S-EPMC5470838 | biostudies-literature
| S-EPMC9589005 | biostudies-literature
| S-EPMC6517313 | biostudies-literature
| S-EPMC5299473 | biostudies-literature